Dermatology News

Health care professionals are more likely to experience mental health issues than other workers in the United States, but the stigma they face often deters them from seeking treatment, leading to tragic outcomes, a speaker said.

The FDA has cleared an investigational new drug application for a first-in-human phase 1/2 study of ATR-04 for moderate to severe dermal toxicity from epidermal growth factor receptor inhibitors, Azitra Inc. announced in a press release.

An expert discussed the downsides of “baby Botox” after Simone Biles opened up about her experience with the cosmetic procedure on social media.

Most physicians receive a regular paycheck, and sometimes receive a lump sum such as a bonus. A proportion of both should be invested. How should one invest a portion of their regular paycheck?

Patients who followed a plant-based diet experienced hair growth with the addition of a daily vegan nutraceutical, according to a study.

Timber Pharmaceutical’s study investigating the use of a new topical ointment formulation of isotretinoin for moderate to severe congenital ichthyosis did not achieve its endpoints, LEO Pharma announced in a press release.

Otezla is now available in the U.S. for the treatment of moderate to severe plaque psoriasis in children and adolescents aged 6 years and older, Amgen announced in a press release.

Individuals with moderate to severe psoriasis experience work absenteeism more than those with a mild form of the disease, according to a study.

A federal judge has blocked the Federal Trade Commission’s ban on new noncompete agreements with all workers in for-profit organizations.

Guselkumab can effectively and safely treat patients with psoriasis for up to 2 years, according to a study.